Literature DB >> 6393999

Bacterial endotoxins: chemical structure and biologic activity.

E T Rietschel, U Zähringer, H W Wollenweber, G Miragliotta, J Musehold, T Lüderitz, U Schade.   

Abstract

Mesh：

Substances：

Year:  1984        PMID： 6393999     DOI： 10.1016/0735-6757(84)90110-4

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN： 0735-6757            Impact factor:   2.469


× No keyword cloud information.
  8 in total

1.  Global and Targeted Lipid Analysis of Gemmata obscuriglobus Reveals the Presence of Lipopolysaccharide, a Signature of the Classical Gram-Negative Outer Membrane.

Authors:  Rajendra Mahat; Corrine Seebart; Franco Basile; Naomi L Ward
Journal:  J Bacteriol       Date:  2015-10-19       Impact factor: 3.490

2.  New aspects in the treatment of gram-negative bacteraemia and septic shock.

Authors:  I Schedel
Journal:  Infection       Date:  1988       Impact factor: 3.553

Review 3.  [Causes and therapy of organ failure: mediators, their role and therapeutic implications as exemplified by the infected patient].

Authors:  H Neuhof
Journal:  Langenbecks Arch Chir       Date:  1987

4.  FtsH-mediated coordination of lipopolysaccharide biosynthesis in Escherichia coli correlates with the growth rate and the alarmone (p)ppGpp.

Authors:  Michael Schäkermann; Sina Langklotz; Franz Narberhaus
Journal:  J Bacteriol       Date:  2013-02-15       Impact factor: 3.490

5.  Depyrogenation using Plasmas: A Novel Approach for Endotoxin Deactivation Using a Dielectric Barrier Discharge at Atmospheric Pressure.

Authors:  Naman Bhatt; Justin Brier-Jones; Duncan Trosan; Cade Brinkley; Joshua Pecoraro; Jann Smallwood; Andrew Crofton; Samuel Hudson; Wolff Kirsch; Katharina Stapelmann; Steven Shannon
Journal:  Plasma Process Polym       Date:  2021-09-07       Impact factor: 3.872

Review 6.  Reactive oxygen species, antiproteases, and cytokines in sepsis.

Authors:  A Wendel
Journal:  Klin Wochenschr       Date:  1991-12-15

Review 7.  Immunopharmacology of lipid A mimetics.

Authors:  William S Bowen; Siva K Gandhapudi; Joseph P Kolb; Thomas C Mitchell
Journal:  Adv Pharmacol       Date:  2013

8.  Engineering a suite of E. coli strains for enhanced expression of bacterial polysaccharides and glycoconjugate vaccines.

Authors:  Emily J Kay; Marta Mauri; Sam J Willcocks; Timothy A Scott; Jon Cuccui; Brendan W Wren
Journal:  Microb Cell Fact       Date:  2022-04-21       Impact factor: 6.352
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.